PATH has launched a groundbreaking initiative to address the rising burden of hemoglobinopathies—particularly Thalassemia—in ...

COIMBATORE: About 14 districts in Tamil Nadu have received 20 new mobile medical units (MMUs) under the National Health ...

Advancing rare disease care with innovation, trials, and specialised clinics ...

Mitchell is a professor of medicine and vice chair for research in the Division of Endocrinology, Diabetes, and Nutrition at the University of Maryland School of Medicine. During the recent White ...

For centuries, historians have debated whether the “Great Fear” panic in the early days of the French Revolution was driven by the mass hysteria of ignorant peasants or a rational response to the ...

Researchers at Zhengzhou University report evidence that physical frailty is associated with dementia and that genetic background, brain structure, and immunometabolic function may mediate this link.

Exagamglogene autotemcel (exa-cel), a CRISPR-Cas9 gene-edited cell therapy, led to sustained improvements in health-related quality of life (HRQOL) for both adults and adolescents with ...

Arlington, VA –The Centers for Disease Control and Prevention (CDC), on behalf of the U.S. Public Health Service (PHS), has released the 2025 Guidelines for the Management of Occupational Exposure to ...

The new Prescription Drug User Fee Act target date is now December 7, 2025. The Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for ...

Vertex Pharmaceuticals is offering Enlaza Therapeutics more than $2 billion in biobucks through a multitarget drug discovery deal aiming to create new T-cell engagers and small-format drug conjugates.

The American Cancer Society (ACS) has released Prostate Cancer Statistics, 2025, a report on current prostate cancer occurrence and outcomes in the United States. According to the study, prostate ...